Approval · Notice of Compliance 20105 · 2017
NABUMETONE: Notice of Compliance 20105
Issued November 29, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20105
- Date
- November 29, 2017
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Labelling Assessment and Administrative - Transfer of Drug Identification Number (DIN)
- Canadian reference product
- RELAFEN (Smithkline Beecham Pharma, Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NABUMETONE | 02238639 | Marketed |
Medicinal ingredients
- NABUMETONE 500 MG per TAB